Bermuda is emerging as a hub for crypto and DeFi innovation, offering a sophisticated regulatory framework that has attracted companies like GRVT, the first regulated decentralized exchange, and Kraken, which launched its global derivatives venue there. This highlights how smaller, agile nations can bridge cutting-edge financial technologies with robust compliance, setting a precedent for fostering trust and legitimacy in the digital asset space.
Top Stock Movers Now: Nvidia, Hershey, Supermicro, and More
U.S. equities were down at midday, pulled lower by falling tech stocks.
Why Is Cogent Biosciences Stock Trading Higher On Monday?
On Sunday, Cogent Biosciences, Inc. (NASDAQ:COGT) revealed updated clinical results from the Open Label Extension (OLE) portion of the SUMMIT trial of bezuclastinib in patients with non-advanced systemic mastocytosis. Non-advanced systemic mastocytosis is a rare disease that involves mast cell buildup in tissues and organs. Updated clinical data presented at the American Society of Hematology Annual Meeting & Exposition show: 56% mean improvement in Total Symptom Score (TSS) at 24 weeks. 76% of
Nvidia stock falls almost 3% as it faces an antitrust probe in China
Nvidia’s (NVDA) shares fell by almost 3% during mid-day trading on Monday after the Chinese government announced an investigation into the chipmaker. Fellow chipmakers Advanced Micro Devices (AMD) and Marvell (MRVL) also saw their shares fall by 4.4% and 5.2%, respectively.
Omnicom to Purchase Interpublic Group in All-Stock Deal
Omnicom Group (OMC) agreed to acquire Interpublic Group of Cos. (IPG) in an all-stock deal to create
Argentine Oil Output Is Poised to Oust Colombia From South America’s Top Three
(Bloomberg) -- A shale-drilling frenzy in Argentina has put the country on the verge of leapfrogging regional rival Colombia as a top-three crude producer in South America.Most Read from BloombergBrace for a Nationwide Shuffle of Corporate HeadquartersA Chicago Skyscraper Cements the Legacy of a Visionary Postmodern ArchitectCloud Computing Tax Threatens Chicago’s Silicon Valley AmbitionsNYC’s Run-Down Bus Terminal Gets Approval for $10 Billion RevampKansas City Looks Back on its Long, Costly Ri
Eye-Disease Focused Kodiak Sciences Is A Promising 'Turnaround Story For 2025': Analyst Upgrades Stock
Jefferies has upgraded Kodiak Sciences Inc. (NASDAQ:KOD), a biopharmaceutical company focused on retinal (eye) diseases. Kodiak’s lead investigational medicine, tarcocimab, is an anti-VEGF antibody biopolymer conjugate under development for high-prevalence retinal vascular diseases. Tarcocimab is currently being studied in two Phase 3 trials, GLOW2 in diabetic retinopathy and DAYBREAK in patients with wet age-related macular degeneration (wet AMD). Both studies are actively enrolling patients. J